z-logo
open-access-imgOpen Access
23: LENZILUMAB IN HOSPITALIZED BLACK/AFRICAN-AMERICAN COVID-19 PATIENTS: LIVE-AIR PHASE 3 STUDY RESULTS
Author(s) -
Zelalem Temesgen,
Charles D. Burger,
Claudia R. Libertin,
Cameron Durrant,
Dale Chappell,
Omar Ahmed,
Adrian Kilcoyne,
Gabrielle Chappell,
E. O. Jordan,
Andrew D. Badley
Publication year - 2021
Publication title -
critical care medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.002
H-Index - 271
eISSN - 1530-0293
pISSN - 0090-3493
DOI - 10.1097/01.ccm.0000806560.97032.3f
Subject(s) - medicine , covid-19 , betacoronavirus , phase (matter) , coronavirus infections , emergency medicine , virology , intensive care medicine , outbreak , infectious disease (medical specialty) , chemistry , disease , organic chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom